key: cord-0685269-utx85z16 authors: Joshi, Jyoti; Payyappalimana, Unnikrishnan; Puthiyedath, Rammanohar title: Potential for supportive Ayurvedic care in hypoxemic COVID-19 patients date: 2021-05-07 journal: J Ayurveda Integr Med DOI: 10.1016/j.jaim.2021.05.001 sha: f08c8f167cae70cdb4ef1ef0d8d94e69744325d3 doc_id: 685269 cord_uid: utx85z16 nan The second wave of COVID-19 has overwhelmed the Indian Health Care system. The system is gasping for breath and hospitals are struggling with oxygen shortage, crunch for beds and ICU facilities with ventilator support. There are frequent reports of patients dying at home, on the road or in hospital corridors due to inadequate access to oxygen support and institutional care. In cities like Mumbai, this situation has prompted many patients to approach Ayurveda practitioners as a desperate supportive option. The Ministry of AYUSH has issued guidelines for practitioners who are treating COVID-19 patients [1] . There are anecdotal accounts of patients getting benefitted by Ayurvedic interventions in severe hypoxic conditions. The purpose of this short communication is to recommend further studies to explore the integration of a specific Ayurvedic intervention in early stages of decreasing peripheral oxygen saturation levels. Due to the unprecedented challenge posed by the escalation of the pandemic, Ayurveda physicians are caring for COVID-19 patients in intensive care settings with the consent of the patients as well as treating physicians or in home settings with the consent of the family members as add on therapy. Our recommendations are based on outcomes observed in several patients with low SpO2 readings following continuous sublingual administration of classical Ayurvedic formulations like Shaddharana Churnam, Apamarga Ksharam, Pippali Churnam, Rasasinduram and Naradiya Lakshmi Vilasa Rasam in divided microdoses. Ministry of AYUSH is dynamically updating the classical Ayurvedic formulations that are used by Ayurvedic practitioners for management of COVID-19 [1]. 1. A 34-year-old male presented to the first author with breathlessness and oxygen saturation levels dipping below 90% (30/09/20). Within three hours of sub-lingual administration of Ayurvedic medicines every 10 minutes, SpO2 readings improved to 94%. The next day, the readings were in the range of 95-97% (01/10/20). Subsequently, it was well maintained at 98-99% (02/10/20) and the patient recovered. This particular patient was treated during the first wave of the pandemic in India and has a long follow up without any further deterioration or complications. A 75-year-old gentleman with diabetes was admitted to hospital due to worsening symptoms after testing positive for COVID-19 (01/04/21). He was discharged after two weeks (16/04/21) and was advised home oxygenation for 30 days as his pulse oximetry readings fluctuated between 80 and 85%. He was advised to follow up after a week. Five days after discharge (21/04/21), the patient approached the first author of this communication and was administered Ayurvedic medicines sublingually. In about eight hours, the oxygen saturation increased to 89 from 81% and in the next four hours to 95%. On the third day of starting Ayurvedic treatment, oxygen saturation was found to be maintained at 97% (23/04/21). Oxygen supplementation could be completely withdrawn, three weeks earlier than recommended, and within three days of initiation of the Ayurvedic treatment. The patient is recovering and is continuing the Ayurvedic medications. year-old female was tested positive for COVID-19 with symptoms like loss of smell and taste, fatigue, body ache and breathlessness on exertion. Oxygen saturation levels decreased to below 90% and patient complained of increasing breathing difficulty. She approached the first author for Ayurvedic treatment (11/04/2021). In about six hours after initiation of Ayurvedic treatment, the pulse oximetry reading improved to 93% and within twelve hours to 95%. The patient also reported symptomatic improvement. Five days later, the SpO2 reading was 96% (16/04/2021) and two weeks later, the patient was found to be asymptomatic and oxygen saturation was well maintained at 97% (25/04/2021). A woman in her eighties with worsening respiratory distress following diagnosis of COVID-19 by rapid antigen test could not be admitted to a hospital due to nonavailability of beds and was in home quarantine. Despite receiving supplemental oxygen (5-6 L/min) at home, her pulse oximetry readings hovered around 45-48%. Breathing was labored with abnormal breath sounds. The family approached an Ayurveda general practitioner, the first author of this communication, seeking medical intervention (26/04/21). Continuous sub-lingual administration of Ayurvedic medicines at an interval of 10 minutes was seen to improve oxygen saturation levels to 78% within four hours. It further increased to 87% with patient showing signs of clinical improvement by sitting up on the bed and responding to questions six hours after starting Ayurvedic treatment. There was panic in the family when other members of the household taking care of the patient tested positive for COVID-19 and sub-lingual administration of Ayurvedic medicines for our patient was discontinued the next day. In a short time, oxygen saturation levels dropped to 63% but patient was still sitting up and conscious. Sublingual administration of Ayurvedic medicines was initiated again, and oxygen saturation levels improved once again to 77 and further around 90% in a span of four to five hours. Subsequently, oxygen supply was exhausted, and the patient did not receive further care as family members reported sick due to symptoms of COVID-19. CRP was 79 mg/L on 26/04/21 before starting Ayurvedic treatment. On 27/04/21, it was found to be 53 mg/L. D. Dimer and Ferritin were within normal range but there were no previous lab reports for comparison. IL-6 was 48 pg/ml, LDH was 868.7 U/L and SGOT was 82.3 U/L, which were all elevated, but could not be compared with any previous readings. The patient died the next day (28/04/21). Based on the observations in these patients and many others, we are reporting the beneficial outcomes of Ayurvedic interventions in hypoxia that seems to have the potential to supplement standard of care for COVID-19. We suggest that such interventions could minimize the burden on intense hospital care by reducing the need for oxygen supplementation. It has also been observed in other patients that Ayurvedic intervention in early stages of decreasing peripheral oxygen saturation can possibly prevent the need for oxygen supplementation and hospitalization. A published case series reported poor outcomes in SpO2 readings and clinical outcomes even with oxygen supplementation and standard of care in similar patients [2] . An exploratory study pointed to the potential of Kinin B2 Receptor Antagonist to reduce oxygen need in COVID-19 patients [3] . A systematic documentation of COVID-19 cases presenting with low SpO2 readings and managed with Ayurvedic interventions is in progress and will be reported as a Case Series. The team is studying the data for possible inconsistencies in responses, dose-response relationship, and any possible adverse effects. Rigorous clinical studies need to be conducted to explore the possibility of integrating this Ayurvedic intervention with standard of care for administration in appropriate stages of hypoxia. Pre-hospital critical care management of severe hypoxemia in victims of Covid-19: a case series Outcomes Associated with Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 Pre-hospital critical care management of severe hypoxemia in victims of Covid-19: a case series Outcomes Associated with Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 J o u r n a l P r e -p r o o f ☐ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☒The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Unnikrishnan Payyappallimana, the second author of the correspondence, is in the editorial team of the journal but will not participate in editorial review of the submission.